Advanced Asset Management Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Advanced Asset Management Advisors's IBB Position: Q2 2026 in Review
Advanced Asset Management Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 180 shares worth $34.2K. The position accounts for 0.01% of the portfolio, ranked #73.
Advanced Asset Management Advisors first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $45K in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Advanced Asset Management Advisors held 180 shares of iShares Biotechnology ETF worth $34.2K as of Q2 2026.
- Advanced Asset Management Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.01% of Advanced Asset Management Advisors's portfolio in Q2 2026, its #73 holding.
- Advanced Asset Management Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
- Advanced Asset Management Advisors's iShares Biotechnology ETF position peaked at $45K in Q1 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Advanced Asset Management Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.